Investigating the Role of mSlap2 in Gfi1-mediated Inhibition of Erk1/2
Download pdf
Abstract/Description: | Gfi1 is known as a nuclear transcriptional repressor that positively regulates B and T cell development and is required for the development of granulocytes. Gfi1 supports granulocyte differentiation at the expense of monocyte differentiation by repressing genes encoding Monocyte-Colony Stimulating Factor (M-CSF) and PU.1, which favor monocyte differentiation. However, the molecular mechanisms by which Gfi1 acts in myeloid development remain incompletely understood. For instance, in contrast to a previous publication reporting that Gfi1 increased the activation of Erk1/2, Dr. Dong’s lab has recently found that Gfi1 inhibits Erk1/2 phosphorylation/activation. The exact pathway leading to Gfi1-mediated inhibition of Erk1/2 activation is yet to be elucidated. Since Gfi1 is a nuclear transcription factor, it is possible that Gfi1 may inhibit Erk1/2 activation by regulating the expression of a cytoplasmic regulator of Erk1/2 activation. In preliminary data obtained from Dr. Dong’s lab, Gfi1 was shown to upregulate the expression of mSlap2. Interestingly, mSlap2 is a cytoplasmic protein that has been shown to inhibit the activation of Erk1/2. We hypothesize that mSlap2 may play a key role in Gfi1-mediated inhibition of Erk1/2 activation in response to Granulocyte-Colony Stimulating Factor (G-CSF). |
---|---|
Subject(s): | hematology; Gfi1; M-CSF; G-CSF; B cells; T cells; monocytes; granulocytes; Erk1/2; mSlap2 |
Title: | Investigating the Role of mSlap2 in Gfi1-mediated Inhibition of Erk1/2. |
|
---|---|---|
Name(s): |
Grim, Allison, author Dong, Fan, author Dr. Fan Dong, advisor |
|
Type of Resource: | text | |
Genre: | poster | |
Other Date: | 2018-03-23 | |
Physical Form: | application/pdf | |
Extent: | 1 p. | |
Abstract/Description: | Gfi1 is known as a nuclear transcriptional repressor that positively regulates B and T cell development and is required for the development of granulocytes. Gfi1 supports granulocyte differentiation at the expense of monocyte differentiation by repressing genes encoding Monocyte-Colony Stimulating Factor (M-CSF) and PU.1, which favor monocyte differentiation. However, the molecular mechanisms by which Gfi1 acts in myeloid development remain incompletely understood. For instance, in contrast to a previous publication reporting that Gfi1 increased the activation of Erk1/2, Dr. Dong’s lab has recently found that Gfi1 inhibits Erk1/2 phosphorylation/activation. The exact pathway leading to Gfi1-mediated inhibition of Erk1/2 activation is yet to be elucidated. Since Gfi1 is a nuclear transcription factor, it is possible that Gfi1 may inhibit Erk1/2 activation by regulating the expression of a cytoplasmic regulator of Erk1/2 activation. In preliminary data obtained from Dr. Dong’s lab, Gfi1 was shown to upregulate the expression of mSlap2. Interestingly, mSlap2 is a cytoplasmic protein that has been shown to inhibit the activation of Erk1/2. We hypothesize that mSlap2 may play a key role in Gfi1-mediated inhibition of Erk1/2 activation in response to Granulocyte-Colony Stimulating Factor (G-CSF). | |
Identifier(s): | 2017_scholcel_allisongrim_mSlap2 (IID) | |
Subject(s): |
hematology; Gfi1; M-CSF; G-CSF; B cells; T cells; monocytes; granulocytes; Erk1/2; mSlap2 |
|
Held by: | University of Toledo Digital Repository | |
Location: | University of Toledo Digital Repository | |
Rights Statement: | http://rightsstatements.org/vocab/InC/1.0/ -- In Copyright | |
Related Title: |
|
|
In Collections: |